Decreased PEMT Gene Expression In The Liver Is Linked To Severity In Nonalcoholic Fatty Liver Disease

PHOENIX, Ariz. — August 22, 2022 — Nonalcoholic fatty liver disease (NAFLD) is both increasingly common and potentially deadly; yet its causes remain poorly understood. Now, a collaborative team of researchers at the Translational Genomics Research Institute (TGen), part of City of Hope, and Temple University has uncovered a link between decreases in an enzyme that makes choline in the liver —an essential nutrient for humans— and severity of NAFLD.

Continue reading

President Trump Unveils Four Industry Related Executive Orders on Friday July 24th

Your Opportunity to Virtually Join the Arizona MedTech Thank You Tour

This week AZBio will be in Washington, D.C. meeting with our Arizona Congressional Delegation and thanking them for their work and support in permanently repealing the Medical Device Excise Tax.   AZBio will be joining medtech leaders from across the country as part of the annual AdvaMed Fly-In.  Even if you are not able to be with us LIVE in Washington, D.C.  you can share your thanks with your Representative and Senators electronically by clicking here. Continue reading

Calling on Congress to Repeal The Medical Device Excise Tax

On September 24, 2019, a letter was sent to Congressional Leaders in the Senate and House leadership on behalf of  a group of over six hundred innovators, patient groups, physicians, hospitals, venture capitalists and other stakeholders representing millions of patients and hundreds of thousands medical technology jobs,  requesting that Congress prioritize repeal of the medical device excise tax before it causes any more harm to the innovation ecosystem. Continue reading